| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,020 |
1,922 |
$114K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
572 |
553 |
$59K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,531 |
1,317 |
$51K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
413 |
413 |
$35K |
| 90461 |
|
501 |
489 |
$18K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
214 |
214 |
$18K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
188 |
187 |
$15K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,567 |
1,565 |
$14K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,300 |
1,244 |
$14K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
125 |
125 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
96 |
96 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
137 |
137 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
252 |
250 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
174 |
173 |
$5K |
| 96127 |
|
333 |
333 |
$3K |
| 99051 |
|
183 |
180 |
$3K |
| 83655 |
|
104 |
104 |
$1K |
| 85018 |
|
500 |
500 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
75 |
75 |
$915.75 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
22 |
22 |
$755.70 |
| 81003 |
|
320 |
316 |
$655.79 |
| 99173 |
|
14 |
14 |
$311.08 |
| 92587 |
|
13 |
13 |
$225.03 |